AUSTIN, Texas--(BUSINESS WIRE)--Selenium, Ltd. announced today the receipt of a Small Business Technology Transfer (STTR) grant from the National Institutes of Health in support of the development of antimicrobial dental devices and water lines. The company’s SeLECTTM technology addresses the needs of many biomedical and industrial companies for a less expensive, more effective, and safer antimicrobial or antineoplastic coating technology. Dr. Julian Spallholz and Dr. Ted Reid are Co-Chief Scientists of Selenium and both are professors at Texas Tech University. Selenium, Ltd. is funded and managed by life sciences venture firm, Emergent Technologies, Inc. (ETI).
